| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.001 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.001 |